Cargando…
1608P The impact of COVID-19 on the delivery of systemic anti-cancer treatment at Guy’s Cancer Centre
Autores principales: | Dolly, S., Russell, B., Moss, C.L., Tsotra, E., Gousis, C., Roca, J., Sita-Lumsden, A., Khan, M., Josephs, D., Zaki, K., Smith, D., Michalarea, V., Kristeleit, R., Enting, D., Flanders, L., Lei, M., Sawyer, E., Spicer, J., Ross, P., Montes, A., Van Hemelrijick, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454366/ http://dx.doi.org/10.1016/j.annonc.2021.08.1601 |
Ejemplares similares
-
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre
por: Russell, Beth, et al.
Publicado: (2022) -
Impact of the COVID-19 Pandemic in Treating Breast Cancer (BC) Patients Receiving Systemic Anti-cancer Treatment (SACT): The Guy's Cancer Centre Experience
por: Gousis, C., et al.
Publicado: (2022) -
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
por: Russell, Beth, et al.
Publicado: (2020) -
Guy’s cancer cohort – real world evidence for cancer pathways
por: Moss, C., et al.
Publicado: (2020) -
Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London
por: Russell, Beth, et al.
Publicado: (2021)